The Fly

Pfizer dismisses Moderna claim it copied COVID-19 shot, CNBC reports

Pfizer (PFE) has dismissed claims made by rival Moderna (MRNA) that its COVID-19 vaccine is a copy, accusing the company of rewriting history, CNBC’s Spencer Kimball reports. Pfizer asked a federal court in Massachusetts this week to reject Moderna’s lawsuit seeking monetary damages for alleged patent violations, with Pfizer requesting the court stop Moderna from suing it or its partners again over three alleged infringements, the author notes. Reference Link

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on MRNA:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More